JP2004513093A - 安定注射液用の組成物および方法 - Google Patents

安定注射液用の組成物および方法 Download PDF

Info

Publication number
JP2004513093A
JP2004513093A JP2002535640A JP2002535640A JP2004513093A JP 2004513093 A JP2004513093 A JP 2004513093A JP 2002535640 A JP2002535640 A JP 2002535640A JP 2002535640 A JP2002535640 A JP 2002535640A JP 2004513093 A JP2004513093 A JP 2004513093A
Authority
JP
Japan
Prior art keywords
component
glass
composition
particles
sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002535640A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004513093A5 (zh
Inventor
ブルース、ジョセフ、ローザー
アルカディオ、ガルシア、デ、カストロ
ジェームズ、マキ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Biostability Ltd
Original Assignee
Cambridge Biostability Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Biostability Ltd filed Critical Cambridge Biostability Ltd
Publication of JP2004513093A publication Critical patent/JP2004513093A/ja
Publication of JP2004513093A5 publication Critical patent/JP2004513093A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2002535640A 2000-10-13 2000-10-13 安定注射液用の組成物および方法 Withdrawn JP2004513093A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/028244 WO2002032402A1 (en) 2000-10-13 2000-10-13 Composition and method for stable injectable liquids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2003383800A Division JP4027881B2 (ja) 2003-11-13 2003-11-13 安定注射液用の組成物および方法

Publications (2)

Publication Number Publication Date
JP2004513093A true JP2004513093A (ja) 2004-04-30
JP2004513093A5 JP2004513093A5 (zh) 2005-08-04

Family

ID=21741883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002535640A Withdrawn JP2004513093A (ja) 2000-10-13 2000-10-13 安定注射液用の組成物および方法

Country Status (12)

Country Link
EP (1) EP1328255A1 (zh)
JP (1) JP2004513093A (zh)
KR (1) KR20030096224A (zh)
CN (1) CN100339066C (zh)
AU (2) AU1198601A (zh)
CA (2) CA2424656C (zh)
ES (1) ES2337252T3 (zh)
MX (1) MXPA03003236A (zh)
NO (1) NO20031706D0 (zh)
PL (1) PL360052A1 (zh)
PT (1) PT1452171E (zh)
WO (1) WO2002032402A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009510156A (ja) * 2005-10-04 2009-03-12 ケンブリッジ バイオスタビリティ リミテッド ガラス状粒子中で安定化した医薬組成物
WO2009091017A1 (ja) * 2008-01-18 2009-07-23 Asahi Kasei Pharma Corporation 安定な医薬組成物

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050267222A1 (en) * 2002-10-22 2005-12-01 Dainippon Pharmaceutical Co. Ltd. Stabilized composition
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
KR20070009639A (ko) 2004-04-13 2007-01-18 캠브리지 바이오스테빌리티 리미티드 부유 유리 입자를 함유한 액체
GB0408199D0 (en) * 2004-04-13 2004-05-19 Cambridge Biostability Ltd Liquids containing suspended sugar glass particles
GB0523638D0 (en) * 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8946200B2 (en) 2006-11-02 2015-02-03 Southwest Research Institute Pharmaceutically active nanosuspensions
US8404850B2 (en) 2008-03-13 2013-03-26 Southwest Research Institute Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
US8722706B2 (en) 2008-08-15 2014-05-13 Southwest Research Institute Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
US8309134B2 (en) 2008-10-03 2012-11-13 Southwest Research Institute Modified calcium phosphate nanoparticle formation
WO2010146536A1 (en) 2009-06-18 2010-12-23 Koninklijke Philips Electronics N.V. Suspension of particles with drug
WO2011007327A2 (en) 2009-07-16 2011-01-20 Koninklijke Philips Electronics N.V. Suspension for therapeutic use and device for delivering said suspension
ES2362525B8 (es) 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
US9028873B2 (en) 2010-02-08 2015-05-12 Southwest Research Institute Nanoparticles for drug delivery to the central nervous system
TWI654098B (zh) 2014-03-24 2019-03-21 日商精工愛普生股份有限公司 Belt printing device and tape printing system
RU2016141948A (ru) * 2014-03-27 2018-04-27 Новартис Аг Высушенные распылением дисперсии твердое-в-масле-в-воде активных фармацевтических ингредиентов для ингаляции

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78151B (zh) * 1982-04-05 1984-09-26 Alcon Lab Inc
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
WO1993018748A1 (en) * 1992-03-19 1993-09-30 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
GB9705588D0 (en) * 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US6190701B1 (en) * 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009510156A (ja) * 2005-10-04 2009-03-12 ケンブリッジ バイオスタビリティ リミテッド ガラス状粒子中で安定化した医薬組成物
WO2009091017A1 (ja) * 2008-01-18 2009-07-23 Asahi Kasei Pharma Corporation 安定な医薬組成物
JP2013177415A (ja) * 2008-01-18 2013-09-09 Asahi Kasei Pharma Kk 安定な医薬組成物
JP5301468B2 (ja) * 2008-01-18 2013-09-25 旭化成ファーマ株式会社 安定な医薬組成物
US9006225B2 (en) 2008-01-18 2015-04-14 Asahi Kasei Pharma Corporation Stable pharmaceutical composition

Also Published As

Publication number Publication date
CN100339066C (zh) 2007-09-26
CA2689856A1 (en) 2002-04-25
NO20031706L (no) 2003-04-11
NO20031706D0 (no) 2003-04-11
WO2002032402A1 (en) 2002-04-25
CA2689856C (en) 2013-09-24
AU2001211986B2 (en) 2007-04-26
KR20030096224A (ko) 2003-12-24
CN1527699A (zh) 2004-09-08
CA2424656A1 (en) 2002-04-25
PL360052A1 (en) 2004-09-06
PT1452171E (pt) 2010-03-08
MXPA03003236A (es) 2004-12-03
AU1198601A (en) 2002-04-29
CA2424656C (en) 2010-03-23
ES2337252T3 (es) 2010-04-22
EP1328255A1 (en) 2003-07-23

Similar Documents

Publication Publication Date Title
US6190701B1 (en) Composition and method for stable injectable liquids
CA2689856C (en) Composition and method for stable injectable liquids
EP1750668B1 (en) Liquids containing suspended glass particles
AU2001211986A1 (en) Composition and method for stable injectable liquids
TWI260988B (en) Lipophilic-coated microparticles containing a protein drug or antigen and formulation comprising same
EA001873B1 (ru) Стабильная частица в жидких композициях
JP2001524533A (ja) 粒子状ワクチン組成物の経皮的送達
KR20030020294A (ko) 분말 조성물
JP2011514337A (ja) 糖ガラス化ウィルス様粒子（ｖｌｐ）
IL189402A (en) Method of producing a dry powder comprising a cellular material and powder produced by such method
KR102624471B1 (ko) 가스 충전된 미세소포
CA2438108C (en) Improved drug formulation of soluble glass particles suspended in a liquid
WO2004073735A1 (en) Improved anthrax vaccines and delivery methods
AU2005203369B2 (en) Pharmaceutical liquid suspensions
JP4027881B2 (ja) 安定注射液用の組成物および方法
JP4382706B2 (ja) 医薬液体懸濁物
KR100796220B1 (ko) 미립자 전달 시스템 및 사용 방법
EP1452171B1 (en) Pharmaceutical liquid suspensions
RU2259817C2 (ru) Композиция для доставки стабильных инъецируемых жидкостей и способ доставки
KR100743442B1 (ko) 약제적 액체 현탁액
NZ525026A (en) A two-component composition comprising particles of sugar glass and a biocompatible liquid perfluorocarbon
CN100594937C (zh) 稳定的注射液组合物和方法
NZ538681A (en) A pharmaceutical composition comprising active biological ingredient carried by particles that form a stable suspension in a liquid indefinitely
CN1997355A (zh) 经肺的疟疾疫苗
RU2003113537A (ru) Композиция для доставки стабильных инъецируемых жидкостей и способ доставки

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060905

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20061205

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20061212

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20070305

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070305